The government has proposed extending the compliance deadline for revised Schedule M norms for pharmaceutical manufacturing.

Let's look at the transformative impact of AI and ML on financial risk management, their potential and the challenges that ...

Nearly half of India's 10,000 drug manufacturing units might not meet the 2025 deadline for upgrading to revised Schedule M ...

As the pharmaceutical industry ... pose potential problems for companies in the industry. This makes the need for effective security and risk management ever more important – and an intelligence ...

In an era where healthcare advancements are at their peak, an often overlooked, yet critical, aspect is the management of pharmaceutical waste. This intricate balance of cost, compliance ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Ivalua, a global leader in spend management, and its partner integrator Fluxym, today announced that Laboratoires Théa (Théa) ...

"The state FDA has formed a team in collaboration with the central team to encompass those factories omitted in the risk-based inspection ... and the state's pharma industry contributes ...

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

The Department of Health and Human Services, Office of Inspector General (“OIG”) recently released a favorable advisory opinion, OIG Advisory ...

The “Vietnam Post Operative Nausea and Vomiting Market ” offers a quantitative analysis of the relevant industry. Quantitative research is data-driven and looks for pertinent patterns in data acquired ...

The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...